Radiofrequency enhances drug release from responsive nanoflowers for hepatocellular carcinoma therapy.
Yanyan WenNingning SongYueyou PengWeiwei WuQixiong LinMinjie CuiRongrong LiQiufeng YuSixue WuYongkang LiangWei TianYanfeng MengPublished in: Beilstein journal of nanotechnology (2024)
Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor and the third leading cause of cancer death worldwide. Most patients are diagnosed at an advanced stage, and systemic chemotherapy is the preferred treatment modality for advanced HCC. Curcumin (CUR) is a polyphenolic antineoplastic drug with low toxicity obtained from plants. However, its low bioavailability and poor solubility limit its functionality. In this study, radiofrequency- (RF) enhanced responsive nanoflowers (NFs), containing superparamagnetic ferric oxide nanoclusters (Fe 3 O 4 NCs), - CUR layer, - and MnO 2 (CUR-Fe@MnO 2 NFs), were verified to have a thermal therapeutic effect. Transmission electron microscopy was used to characterize the CUR-Fe@MnO 2 NFs, which appeared flower-like with a size of 96.27 nm. The in vitro experimental data showed that RF enhanced the degradation of CUR-Fe@MnO 2 NFs to release Mn 2+ and CUR. The cytotoxicity test results indicated that after RF heating, the CUR-Fe@MnO 2 NFs significantly suppressed HCC cell proliferation. Moreover, CUR-Fe@MnO 2 NFs were effective T 1 / T 2 contrast agents for molecular magnetic resonance imaging due to the release of Mn 2+ and Fe 3 O 4 NCs.
Keyphrases
- metal organic framework
- magnetic resonance imaging
- cell proliferation
- drug release
- end stage renal disease
- electron microscopy
- ejection fraction
- newly diagnosed
- computed tomography
- chronic kidney disease
- peritoneal dialysis
- stem cells
- emergency department
- contrast enhanced
- cancer therapy
- ultrasound guided
- bone marrow
- machine learning
- patient reported outcomes
- mesenchymal stem cells
- signaling pathway
- atrial fibrillation
- cell therapy
- quantum dots
- fluorescent probe
- lymph node metastasis
- drug induced
- label free
- combination therapy
- squamous cell